<DOC>
	<DOCNO>NCT00157924</DOCNO>
	<brief_summary>An efficacy safety study ezetimibe ( + ) simvastatin compare atorvastatin week 6 diabetic metabolic syndrome patient Korea .</brief_summary>
	<brief_title>Ezetimibe ( + ) Simvastatin vs. Atorvastatin Comparative Study DM Metabolic Syndrome Patients ( 0653A-093 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Clinical diagnosis hypercholesterolemia Drug naive statin treat inadequately control patient NCEP ATP III guideline goal Hypersensitivity HMGCoA inhibitor Ezetimibe</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>